Nanogroup SA Market Cap ($20.80 Million)
Market Cap & Net Worth: Nanogroup SA (NNG)
Nanogroup SA market cap. Nanogroup SA (WAR:NNG) has a market capitalization of $20.80 Million (zł75.59 Million) as of November 1, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #24844 globally and #244 in its home market, demonstrating a 0.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nanogroup SA's stock price zł2.35 by its total outstanding shares 32164563 (32.16 Million). Also see Nanogroup SA cash flow conversion for how efficiently the company converts equity into cash flow.
Nanogroup SA Market Cap History (2017–2026)
Nanogroup SA market cap history from 2017 to 2026. Data shows change from $28.33 Million to $20.80 Million (-7.07% CAGR). Check Nanogroup SA stock price for real-time trading data and today's change.
Nanogroup SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nanogroup SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore NNG year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
12224.40x
Nanogroup SA's market cap is 12224.40 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $28.33 Million | $40.80K | -$2.01 Million | 694.32x | N/A |
| 2018 | $21.60 Million | $110.29K | -$2.34 Million | 195.84x | N/A |
| 2019 | $13.10 Million | $351.83K | -$1.54 Million | 37.24x | N/A |
| 2020 | $38.77 Million | $687.51K | -$5.19 Million | 56.40x | N/A |
| 2021 | $31.78 Million | $492.49K | -$10.01 Million | 64.53x | N/A |
| 2022 | $11.01 Million | $139.55K | -$838.59K | 78.91x | N/A |
| 2023 | $8.21 Million | $2.02K | -$7.89 Million | 4068.75x | N/A |
| 2024 | $25.67 Million | $2.10K | -$5.17 Million | 12224.40x | N/A |
Competitor Companies of NNG by Market Capitalization
Companies near Nanogroup SA in the global market cap rankings as of November 1, 2026. Also see NNG total assets for a full breakdown of the balance sheet.
Key companies related to Nanogroup SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Nanogroup SA (2017–2026)
Market capitalization of Nanogroup SA from 2017 to today. Between 2017 and today, Nanogroup SA's market cap moved from $28.33 Million to $ 20.80 Million, with a yearly change of -7.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł20.80 Million | -11.32% |
| 2025 | zł23.46 Million | -8.62% |
| 2024 | zł25.67 Million | +212.50% |
| 2023 | zł8.21 Million | -25.40% |
| 2022 | zł11.01 Million | -65.35% |
| 2021 | zł31.78 Million | -18.04% |
| 2020 | zł38.77 Million | +195.95% |
| 2019 | zł13.10 Million | -39.34% |
| 2018 | zł21.60 Million | -23.75% |
| 2017 | zł28.33 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Nanogroup SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.80 Million USD |
| MoneyControl | $20.80 Million USD |
| MarketWatch | $20.80 Million USD |
| marketcap.company | $20.80 Million USD |
| Reuters | $20.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nanogroup SA
NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.